Form4insider filings, from the source

SEC Form 5/A · accession 0000899243-18-004081

Global Blood Therapeutics, Inc. · GBT

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

This is an amendment (Form 5/A). It replaces an earlier filing for the same period.
Reporting owner
Period of report
Dec 31, 2016
Accepted (ET)
Feb 14, 2018 · 9:57 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001629137

Table I — non-derivative securities

SecurityDateCodeSharesPriceA/DOwned afterD/INature of ownership
COMMON STOCKNov 14, 2016J14,611$0.00D223,117D
COMMON STOCKNov 14, 2016J14,611$0.00D14,611IBy Charles Homcy Revocable Trust
COMMON STOCKNov 23, 2016G10,000$0.00D4,611IBy Charles Homcy Revocable Trust
COMMON STOCKDec 23, 2016J10,432$0.00D212,685D
COMMON STOCKDec 23, 2016J10,432$0.00A15,043IBy Charles Homcy Revocable Trust
COMMON STOCKholding———1,600IBy Charles Homcy Irrevocable Trust

Table II — derivative securities

No Table II lines on this filing.

Explanation of responses